SCHEMBL5587529

SCHEMBL5587529

CCCc1c(O)c(O)c(-c2ccccc2)c(CCC)c1CCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
GAA P10253 2/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
RCE1 Q9Y256 1/20 0.38
GCGR P47871 2/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
LDHA P00338 2/20 0.36
LDHB P07195 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589592 0.89 GCGR (0.46) KDM4EALDH1A1HPGDGAAGCGR
SCHEMBL27975915 0.84 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAAESR1
SCHEMBL5589186 0.82 LDHA (0.50) KDM4EALDH1A1HPGDGAAPDE4B
SCHEMBL27467842 0.79 GCGR (0.39) KDM4EALDH1A1HPGDGAAPDE4A
SCHEMBL5587539 0.78 PDE4A (0.46) KDM4EALDH1A1HPGDGAAPDE4A
SCHEMBL5588913 0.77 ESR1 (0.47) KDM4EGAAPDE4APDE4BPDE4C
SCHEMBL5589806 0.77 LDHA (0.49) KDM4EALDH1A1HPGDGCGRLDHA
SCHEMBL5588016 0.76 LDHA (0.48) KDM4EGAAPDE4BPDE4DESR1
SCHEMBL17473174 0.76 ESR1 (0.46) KDM4EALDH1A1HPGDGAAESR1
SCHEMBL5587747 0.74 LDHA (0.39) KDM4EALDH1A1HPGDGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 KDM4E 1868/4885ALDH1A1 2181/4885HPGD 2689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.